Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$689,241
+$110,718 QoQ
Shares Held
2,739
+3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#2,885
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WULFF, HANSEN & CO. holds $6,552,139 across 6 Drug Manufacturers - General names. ABBV ranks #3 (10.5% of the industry book) .
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $689,241 | 2,739 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $578,523 | 2,660 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $607,783 | 2,660 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $635,577 | 2,745 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $509,526 | 2,745 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $575,132 | 2,745 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $487,786 | 2,745 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $547,019 | 2,770 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $475,110 | 2,770 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $566,331 | 3,110 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $488,930 | 3,155 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $470,284 | 3,155 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $483,680 | 3,590 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $607,996 | 3,815 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $616,542 | 3,815 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $514,695 | 3,835 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $587,368 | 3,835 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $621,691 | 3,835 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $725,067 | 5,355 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||